Sonja Leahy
Family · Valencia, CANPI 1861764326
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 232 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by AbbVie at 24.4% of the total. 2025 is the largest year on record at $3,622, more than ten times the $43 reported in 2021. Among family clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 232 payments — averaging $24.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- UCB, Inc.$448
- Pfizer$447
- Neurelis, Inc.$406
- Lilly USA, LLC$393
- Eisai Inc.$322
- plus $2K from 27 others
What the payments were for
- Food & beverage$5,636100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 56 | $1,373 |
| UCB, Inc. | 15 | $448 |
| Pfizer | 20 | $447 |
| Neurelis, Inc. | 15 | $406 |
| Lilly USA, LLC | 18 | $393 |
| Eisai Inc. | 13 | $322 |
| SK Life Science, Inc. | 14 | $321 |
| Tonix Medicines, Inc. | 13 | $251 |
| Novartis | 8 | $226 |
| Teva Pharmaceuticals USA, Inc. | 8 | $186 |
| AstraZeneca(2 entities) | 6 | $128 |
| ANI Pharmaceuticals, Inc. | 4 | $116 |
| Genentech USA, Inc. | 4 | $106 |
| Lundbeck LLC | 4 | $91 |
| Bristol Myers Squibb | 4 | $81 |
| Merz Pharmaceuticals, LLC | 3 | $73 |
| EMD Serono, Inc. | 2 | $67 |
| Merz North America, Inc. | 2 | $63 |
| Octapharma USA, Inc. | 2 | $62 |
| MDD US Operations, LLC | 3 | $59 |
| Neurocrine Biosciences, Inc. | 2 | $58 |
| Amgen | 2 | $55 |
| Biogen | 2 | $50 |
| Amneal Pharmaceuticals LLC | 2 | $45 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| Cycle Pharmaceuticals Inc | 2 | $27 |
| Acadia Pharmaceuticals Inc | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Abbott | 1 | $24 |
| Grifols USA, LLC | 1 | $22 |
| CSL Behring | 1 | $19 |
| Livanova USA, Inc. | 1 | $18 |
| Biomarin Pharmaceutical Inc. | 1 | $17 |
How this compares
$5,636 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 104 | $1,682 |
| Levetiracetam | 27 | $787 |
| Lamotrigine | 12 | $395 |
| Ofloxacin | 16 | $257 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $243 |
| Divalproex Sodium | 13 | $243 |
| Primidone | 14 | $231 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $196 |
| Doxycycline Monohydrate | 11 | $127 |
| Gabapentin | 20 | $105 |
| Donepezil Hcl | 17 | $77 |
| Sertraline Hcl | 15 | $52 |
Paid to pharmacies, not to this prescriber.
Other family in Valencia
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.